title: Effects of growth hormone releasing factor on pancreatic secretion in vivo and in vitro.
abstract: Growth hormone releasing factor (GRF), a 44-residue peptide originally isolated from human pancreatic tumors, shows structural similarities to the members of the secretin-vasoactive intestinal peptide (VIP) peptides. This study was designed to determine the effects of human GRF (hGRF-(1-44] on pancreatic secretion in vivo in conscious dogs and in vitro in dispersed rat pancreatic acini. GRF given i.v. in graded doses in dogs caused a small but significant stimulation of pancreatic HCO3- and protein outputs and potentiated secretin- and cholecystokinin (CCK)-induced pancreatic HCO3- but not protein secretion. When given together with somatostatin, GRF failed to reverse the inhibitory action of this peptide on HCO3- and protein responses to secretin plus CCK in dogs. Studies in vitro dispersed rat pancreatic acini showed that GRF added to the incubation medium of these acini caused an increase in basal amylase release and shifted to the left the amylase dose-response curve to caerulein and urecholine but failed to affect the amylase response to VIP. This study indicates that GRF in vivo stimulates basal and augments secretin- or CCK-induced pancreatic HCO3- secretion and that this is probably due to direct stimulatory action of the peptide on pancreatic secretory cells.
authors: Institute of Physiology, Academy of Medicine, Krakow, Poland.
authors: S J
authors: SJ
authors: Konturek
authors: J
authors: J
authors: Bilski
authors: J
authors: J
authors: Jaworek
authors: T
authors: T
authors: Mochizuki
authors: C
authors: C
authors: Yanaihara
authors: N
authors: N
authors: Yanaihara
mesh_terms: D000681:Amylases / Q000378:metabolism; D000818:Animals; D001639:Bicarbonates / Q000378:metabolism*; D002108:Ceruletide / Q000494:pharmacology; D002766:Cholecystokinin / Q000494:pharmacology; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D013007:Growth Hormone-Releasing Hormone / Q000494:pharmacology*; D010179:Pancreas / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D011506:Proteins / Q000378:metabolism; D051381:Rats; D012633:Secretin / Q000494:pharmacology; D013004:Somatostatin / Q000494:pharmacology; D014660:Vasoactive Intestinal Peptide / Q000494:pharmacology
chemical_list: D001639:Bicarbonates; D011506:Proteins; D012633:Secretin; D014660:Vasoactive Intestinal Peptide; D013004:Somatostatin; D002108:Ceruletide; D002766:Cholecystokinin; D013007:Growth Hormone-Releasing Hormone; D000681:Amylases